CVS HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.5 USD | -1.62% |
|
-0.15% | -13.25% |
| Apr. 22 | Leerink Partners Adjusts Price Target on CVS Health to $87 From $88 | MT |
| Apr. 17 | CVS, Cigna, Humana, UnitedHealth - Congress wants to clean up PBMs |  |
Chart calendar CVS Health Corporation
638fc4427e.6cni_j6XXUXo5Aaea8OG4Vrt4Dn6VflTOvOr08jxCWE.3bqkv1zRbyHdpkvzDpfAoCzcq2G_MbUHXcTCvJy8XTixnKu5DNk2MZ-LVw~db660cbee1c2ecc27fac465cfadab1d4
Upcoming events on CVS Health Corporation
Past events on CVS Health Corporation
| 2024-04-18 | Ex-dividend day |
| 2024-04-14 09:30 pm | Shareholders Meeting |
| 2024-03-05 09:50 am | Raymond James Institutional Investors Conference - Fireside Chat |
| 2024-02-27 | Non Deal Roadshow - Wolfe Research |
| 2024-02-07 08:00 am | Q4 2023 Earnings Call |
| 2024-02-07 06:30 am | Q4 2023 Earnings Release |
| 2024-01-18 | Ex-dividend day |
| 2024-01-08 10:30 am | JPMorgan Healthcare Conference |
| 2023-12-05 08:00 am | Investor Day |
| 2023-11-01 08:00 am | Q3 2023 Earnings Call |
| 2023-11-01 06:30 am | Q3 2023 Earnings Release |
| 2023-10-18 | South West Connect Conference |
| 2023-10-18 | Ex-dividend day |
| 2023-09-12 08:50 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-27 | RISE West Conference |
| 2023-08-02 08:00 am | Q2 2023 Earnings Call |
| 2023-08-02 06:30 am | Q2 2023 Earnings Release |
| 2023-07-27 04:15 am | June 2023 Sales and Revenue Release - Activities Report |
| 2023-07-19 | Ex-dividend day |
| 2023-05-31 09:00 am | Bernstein Strategic Decisions Conference |
Past dividends on CVS Health Corporation
| 2024-04-18 | Quarterly 0.665 USD |
| 2024-01-18 | Quarterly 0.665 USD |
| 2023-10-18 | Quarterly 0.605 USD |
| 2023-07-19 | Quarterly 0.605 USD |
| 2023-04-19 | Quarterly 0.605 USD |
| 2023-01-18 | Quarterly 0.605 USD |
| 2022-10-19 | Quarterly 0.55 USD |
| 2022-07-20 | Quarterly 0.55 USD |
| 2022-04-20 | Quarterly 0.55 USD |
| 2022-01-19 | Quarterly 0.55 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 256 776 253 934 1.12% | 268 706 267 982 0.27% | 292 111 290 928 0.41% | 322 467 314 696 2.47% | 357 776 354 613 0.89% | 370 818 |
|
EBITDA Million USD | Released Forecast Spread | 17 274 17 260 0.08% | 18 108 18 119 -0.06% | 19 565 19 266 1.55% | 19 971 20 122 -0.75% | 19 995 19 955 0.2% | 19 571 |
|
EBIT Million USD | Released Forecast Spread | 15 339 15 324 0.09% | 16 008 15 821 1.18% | 17 312 17 054 1.51% | 17 532 17 525 0.04% | 17 534 17 388 0.84% | 16 758 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8 997 8 904 1.04% | 9 770 10 471 -6.69% | 10 420 10 892 -4.33% | 5 628 5 497 2.38% | 11 173 11 515 -2.97% | 11 825 |
|
Net income Million USD | Released Forecast Spread | 6 634 6 573 0.93% | 7 179 7 520 -4.54% | 7 910 8 206 -3.6% | 4 149 4 370 -5.06% | 8 344 8 577 -2.71% | 8 843 |
|
EPS USD | Released Forecast Spread | 5,08 5,01 1.38% | 5,46 5,65 -3.35% | 5,95 5,96 -0.1% | 3,14 2,99 4.95% | 6,47 6,69 -3.34% | 6,87 |
| Announcement Date | 12/02/20 | 16/02/21 | 09/02/22 | 08/02/23 | 07/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 76 604 75 470 1.5% | 76 826 75 297 2.03% | 80 636 76 379 5.57% | 81 159 76 782 5.7% | 83 846 76 371 9.79% | 85 278 80 670 5.71% | 88 921 86 528 2.77% | 89 764 88 171 1.81% | 93 813 90 717 3.41% | 89 205 | 92 079 | 92 705 | 96 739 | 94 705 |
|
EBITDA Million USD | Released Forecast Spread | 4 733 4 478 5.69% | 5 070 5 043 0.54% | 5 431 5 003 8.56% | 4 825 4 704 2.58% | 4 645 4 552 2.04% | 4 969 4 744 4.75% | 5 100 4 842 5.34% | 5 074 4 921 3.12% | 4 852 4 693 3.4% | 4 198 | 5 151 | 5 192 | 4 937 | 4 942 |
|
EBIT Million USD | Released Forecast Spread | 4 147 3 918 5.84% | 4 483 4 447 0.8% | 4 810 4 411 9.06% | 4 233 4 108 3.05% | 4 006 3 983 0.57% | 4 370 4 159 5.09% | 4 481 4 260 5.18% | 4 456 4 371 1.94% | 4 227 4 081 3.58% | 3 567 | 4 455 | 4 508 | 4 303 | 4 140 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 570 2 062 -23.84% | 2 946 3 082 -4.41% | 4 029 3 422 17.75% | -4 456 3 088 -244.3% | 3 109 2 944 5.61% | 2 879 3 178 -9.41% | 2 570 3 189 -19.4% | 3 019 3 121 -3.28% | 2 705 2 841 -4.79% | 2 434 | 2 931 | 2 982 | 2 823 | 3 231 |
|
Net income Million USD | Released Forecast Spread | 1 306 1 495 -12.62% | 2 312 2 418 -4.38% | 2 951 2 519 17.17% | -3 416 2 273 -250.29% | 2 302 2 138 7.67% | 2 136 2 276 -6.14% | 1 901 2 350 -19.1% | 2 261 2 317 -2.44% | 2 046 2 159 -5.22% | 1 724 | 2 380 | 2 430 | 2 289 | 2 168 |
|
EPS USD | Released Forecast Spread | 0,98 1,01 -2.95% | 1,74 1,84 -5.6% | 2,23 1,88 18.47% | -2,60 1,73 -250.45% | 1,75 1,61 8.73% | 1,65 1,75 -5.8% | 1,48 1,82 -18.52% | 1,75 1,80 -2.95% | 1,58 1,67 -5.54% | 1,32 | 1,82 | 1,88 | 1,80 | 1,74 |
| Announcement Date | 09/02/22 | 04/05/22 | 03/08/22 | 02/11/22 | 08/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 07/02/24 | - | - | - | - | - |
More events
Past sector events for CVS Health Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CVS Stock
- Calendar CVS Health Corporation
